Recent studies have demonstrated that lipiodol, oily contrast medium, injected into the hepatic artery after selective catheterization by Seldinger's method, specifically binds to primary and metastatic tumours and remains 'in situ' for months. Mixing at lipiodol the antiblastic agent (epirubicin, 20 mg) we have treated, from August 1987, 27 patients (11 female and 15 male, age range 38-75 years) with unresectable liver metastases of digestive tract tumours. Eighteen of this patients were treated once only and 8 patients were treated monthly for 3 times. The size of liver tumour was checked with CT-scan, by computerized measurement of tumour area. We have observed no growth of tumours in all patients, and always the decrease in size of liver tumour after the injection of lipiodol-epirubicin. These results suggest that the antiblastic effect of this mixture is effective for one month, and that the repeated monthly infusions permit the stabilization of the tumour area at 6 months after the first chemoembolization. In all patients side effects of treatment are mild and transient, and we have often observed improvement of clinical conditions.

Intraarterial infusion of lipiodol-epirubicin suspension for treatment of unresectable liver metastases

Carcano G.;Dominioni L.;Benevento A.;Dionigi R.
1991

Abstract

Recent studies have demonstrated that lipiodol, oily contrast medium, injected into the hepatic artery after selective catheterization by Seldinger's method, specifically binds to primary and metastatic tumours and remains 'in situ' for months. Mixing at lipiodol the antiblastic agent (epirubicin, 20 mg) we have treated, from August 1987, 27 patients (11 female and 15 male, age range 38-75 years) with unresectable liver metastases of digestive tract tumours. Eighteen of this patients were treated once only and 8 patients were treated monthly for 3 times. The size of liver tumour was checked with CT-scan, by computerized measurement of tumour area. We have observed no growth of tumours in all patients, and always the decrease in size of liver tumour after the injection of lipiodol-epirubicin. These results suggest that the antiblastic effect of this mixture is effective for one month, and that the repeated monthly infusions permit the stabilization of the tumour area at 6 months after the first chemoembolization. In all patients side effects of treatment are mild and transient, and we have often observed improvement of clinical conditions.
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/11383/2103997
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 0
  • ???jsp.display-item.citation.isi??? ND
social impact